Zataria multiflora extract enhances imatinib-induced cytotoxicity in chronic myeloid leukemia and multiple myeloma cells
Authors:
- Sahar MostajeranSMSahar Mostajeran
- Mohsen EhsanMEMohsen Ehsan
- Mahla LashkariMLMahla Lashkari
- Hajar Mardani ValandaniHVHajar Mardani Valandani
- Ahmad FatemiAFAhmad Fatemi
- Ali BaziABAli Bazi
- Mahdieh MirzaieMMMahdieh Mirzaie
- Muhammad Hossein AshoubMAMuhammad Hossein Ashoub
- Roohollah Mirzaee KhalilabadiRKRoohollah Mirzaee Khalilabadi
- 14 October 2025
- journal article
- research article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 52 (1) , 1-13
Abstract
Background Zataria multiflora (ZM) is a medicinal plant with widespread antitumor effects. Tyrosine kinase inhibitors (TKIs) are considered the mainstay treatment in blood cancers; however, eventual resistance to TKIs poses a significant challenge in this area. The present study aimed to assess the synergistic effects of ZM extract (ZME) along with imatinib, a TKI, against K-562 and U-266 leukemic cell lines. Methods Cell viability was evaluated using the MTT assay, and apoptosis assessment was also conducted through Annexin-V/PI staining. Additionally, Real-Time PCR was used to assess the expression levels of BCR-ABL, P-TEN, c-MYC, Bax, and Bcl-2 genes. Molecular docking was carried out as an in-silico technique for both BCL-2 and ABL proteins. Results The results showed that both ZME and imatinib promoted apoptosis in K562 and U266 cells, with combination treatment significantly enhancing apoptotic cell death (e.g., 18.4% apoptosis in K562 cells with ZME + imatinib vs. 8.5% untreated; 46.9% in U266 cells vs. 11.6% untreated, P < 0.05). Combined treatment with imatinib and ZME upregulated the expression of Bax (5-fold in K562, 3-fold in U266) and P-TEN (2-fold in K562, 2.8-fold in U266) genes and downregulated the expression of Bcl-2 (0.3-fold in K562, 0.3-fold in U266), BCR-ABL (0.5-fold in K562), and c-MYC (0.4-fold in K562, 0.2-fold in U266) genes (P < 0.05). Molecular docking showed strong binding affinities between ZME constituents (carvacrol and thymol) and BCL-2 and ABL proteins. Conclusions ZME shows potential as a complementary agent in vitro, warranting further investigation.Keywords
Funding Information
- Kerman University of Medical Sciences
This publication has 43 references indexed in Scilit:
- Synergistic effect of Zataria Multiflora essential oil on doxorubicin-induced growth inhibition of PC3 cancer cells and apoptosisComplementary Therapies in Clinical Practice, 2021
- AZD4320, A Dual Inhibitor of Bcl-2 and Bcl-xL, Induces Tumor Regression in Hematologic Cancer Models without Dose-limiting ThrombocytopeniaClinical Cancer Research, 2020
- Bcr-Abl Allosteric Inhibitors: Where We Are and Where We Are Going toMolecules, 2020
- Thymol Isolated from Thymus vulgaris L. Inhibits Colorectal Cancer Cell Growth and Metastasis by Suppressing the Wnt/β-Catenin PathwayDrug Design, Development and Therapy, 2020
- Co-inhibition of BCL-XL and MCL-1 with selective BCL-2 family inhibitors enhances cytotoxicity of cervical cancer cell linesBiochemistry and Biophysics Reports, 2020
- In-vitro (2D and 3D cultures) and in-vivo cytotoxic properties of Zataria multiflora essential oil (ZEO) emulsion in breast and cervical cancer cells along with the investigation of immunomodulatory potentialJournal of Ethnopharmacology, 2020
- PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine?Genes, 2020
- Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical PracticeFrontiers in Pharmacology, 2020
- Synergistic Effects of PI3K and c-Myc Co-targeting in Acute Leukemia: Shedding New Light on Resistance to Selective PI3K-δ Inhibitor CAL-101Cancer Investigation, 2019
- Chemical composition along with anti-leishmanial and cytotoxic activity of Zataria multifloraPharmaceutical Biology, 2015